Brevan Howard Capital Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Sell
1,546
-2,522
-62% -$430K ﹤0.01% 1810
2026
Q1
$733K Sell
4,068
-6,202
-60% -$1.23M 0.01% 1080
2025
Q4
$2.23M Buy
10,270
+9,193
+854% +$2.01M 0.02% 453
2025
Q3
$276K Sell
1,077
-17,746
-94% -$4.46M ﹤0.01% 1605
2025
Q2
$4.88M Buy
+18,823
New +$4.79M 0.03% 373
2025
Q1
– Sell
-7,433
Closed -$1.89M – 1238
2024
Q4
$1.89M Buy
+7,433
New +$1.99M 0.01% 296

Other funds holding EFX

Brevan Howard Capital Management's EFX Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Equifax (EFX) stake by 62% in Q2 2026, selling an estimated $430K and leaving 1,546 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Brevan Howard Capital Management first reported a position in EFX in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.88M in Q2 2025. 838 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

  • Brevan Howard Capital Management held 1,546 shares of Equifax worth $245K as of Q2 2026.
  • Brevan Howard Capital Management sold 2,522 Equifax shares in Q2 2026, an estimated $430K.
  • Equifax made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1810 holding.
  • Brevan Howard Capital Management first reported a position in Equifax in Q4 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Equifax position peaked at $4.88M in Q2 2025.
  • 838 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.